Pulse Biosciences (PLSE) Market Capitalization (2016 - 2026)

Pulse Biosciences has reported Market Capitalization for 11 years, with the latest figure at $2.0 billion in Q2 2026.

• On a quarterly basis, Market Capitalization rose 93.38% year-over-year to $2.0 billion in Q2 2026; TTM through Jun 2026 was $2.0 billion, a 93.38% increase from a year earlier, with the FY2025 full-year figure at $931.4 million, down 18.85% from the prior year.
• Market Capitalization was $2.0 billion for Q2 2026 at Pulse Biosciences, up from $931.4 million in the prior quarter.
• The five-year high for Market Capitalization was $2.0 billion in Q2 2026, with the low at $56.8 million in Q2 2022.
• Average Market Capitalization over 5 years is $661.8 million, with a median of $618.0 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Market Capitalization tumbled 88.3% in 2022, then surged 554.41% in 2023.
• Over 5 years, Market Capitalization stood at $103.1 million in 2022, then soared by 554.41% to $675.0 million in 2023, then soared by 70.05% to $1.1 billion in 2024, then dropped by 18.85% to $931.4 million in 2025, then soared by 110.78% to $2.0 billion in 2026.
• The last three Market Capitalization figures came in at $2.0 billion (Q2 2026), $931.4 million (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.